106 related articles for article (PubMed ID: 26536741)
1. [Case Report: A case of living-donor kidney transplantation from a heterozygote mother to a hemizygote son of Fabry disease diagnosed by donated allograft biopsy].
Nishioka R; Sofue T; Moritoki M; Nishijima Y; Nishioka S; Hara T; Kushida Y; Ueda N; Kakehi Y; Kohno M
Nihon Naika Gakkai Zasshi; 2015 Apr; 104(4):775-80. PubMed ID: 26536741
[No Abstract] [Full Text] [Related]
2. Kidney transplantation from a mother with unrecognized Fabry disease to her son with low α-galactosidase A activity: A 14-year follow-up without enzyme replacement therapy.
Odani K; Okumi M; Honda K; Ishida H; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():57-9. PubMed ID: 26971403
[TBL] [Abstract][Full Text] [Related]
3. Unexpected Fabry disease in a renal allograft kidney: an underrecognized cause of poor allograft function.
Kochar O; Wick MR; Kerr SE; Oglesbee D; Cathro HP
Ultrastruct Pathol; 2011 Apr; 35(2):92-6. PubMed ID: 21299350
[TBL] [Abstract][Full Text] [Related]
4. [Renal transplantation in patients suffering from Fabry's disease. Kidney transplantation from an heterozygote subject to a subject without Fabry's disease].
Grünfeld JP; Le Porrier M; Droz D; Bensaude I; Hinglais N; Crosnier J
Nouv Presse Med; 1975 Sep; 4(29):2081-5. PubMed ID: 809752
[TBL] [Abstract][Full Text] [Related]
5. Fabry disease in a renal allograft.
Puliyanda DP; Wilcox WR; Bunnapradist S; Nast CC; Jordan SC
Am J Transplant; 2003 Aug; 3(8):1030-2. PubMed ID: 12859541
[TBL] [Abstract][Full Text] [Related]
6. Pre-existing arteriosclerotic intimal thickening in living-donor kidneys reflects allograft function.
Sofue T; Inui M; Kiyomoto H; Moritoki M; Nishioka S; Nishijima Y; Moriwaki K; Hara T; Kushida Y; Haba R; Yoda T; Hirao T; Kakehi Y; Nishiyama A; Kohno M
Am J Nephrol; 2012; 36(2):127-35. PubMed ID: 22797609
[TBL] [Abstract][Full Text] [Related]
7. Renal transplantation between siblings with unrecognized Fabry disease.
Taneda S; Honda K; Nakajima I; Huchinoue S; Oda H
Transplant Proc; 2013; 45(1):115-8. PubMed ID: 23375284
[TBL] [Abstract][Full Text] [Related]
8. Histological changes of a kidney in a recipient who received an allograft from a patient with Fabry disease.
Fujii H; Kono K; Hara S; Ishimura T; Nishi S
J Nephrol; 2020 Aug; 33(4):657-659. PubMed ID: 32535832
[No Abstract] [Full Text] [Related]
9. Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor.
Kitajima K; Ogawa Y; Miki K; Kai K; Sannomiya A; Iwadoh K; Murakami T; Koyama I; Nakajima I; Fuchinoue S
Liver Transpl; 2017 Mar; 23(3):315-323. PubMed ID: 27862900
[TBL] [Abstract][Full Text] [Related]
10. Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure.
Van Loo A; Vanholder R; Madsen K; Praet M; Kint J; De Paepe A; Messiaen L; Lameire N; Hasholt L; Sørensen SA; Ringoir S
Am J Nephrol; 1996; 16(4):352-7. PubMed ID: 8739292
[TBL] [Abstract][Full Text] [Related]
11. A nonsense mutation (R220X) in the alpha-galactosidase A gene causes typical Fabry disease in both genders.
Maki N; Komatsuda A; Wakui H; Oyama Y; Kodama T; Ohtani H; Kigawa A; Aiba N; Imai H; Motegi M; Yamaguchi A; Sawada K
Clin Nephrol; 2004 Mar; 61(3):185-90. PubMed ID: 15077869
[TBL] [Abstract][Full Text] [Related]
12. Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.
Oh IH; Lee CH; Kim GH; Kang CM; Park JS
Artif Organs; 2015 Mar; 39(3):254-9. PubMed ID: 25205383
[TBL] [Abstract][Full Text] [Related]
13. Fabry disease. Classic hemizygote and residual alpha-galactosidase A activity.
Pravata G; Noto G; Arico M
Int J Dermatol; 1991 May; 30(5):367-9. PubMed ID: 1648549
[No Abstract] [Full Text] [Related]
14. Living renal allograft transplantation: diffusion-weighted MR imaging in longitudinal follow-up of the donated and the remaining kidney.
Eisenberger U; Binser T; Thoeny HC; Boesch C; Frey FJ; Vermathen P
Radiology; 2014 Mar; 270(3):800-8. PubMed ID: 24475796
[TBL] [Abstract][Full Text] [Related]
15. Involvement of renal allograft by Fabry's disease.
Popli S; Molnar ZV; Leehey DJ; Daugirdas JT; Roth DA; Adams MB; Cheng JC; Ing TS
Am J Nephrol; 1987; 7(4):316-8. PubMed ID: 3120588
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of Fabry's disease in a renal allograft 14 years after transplantation.
Gantenbein H; Bruder E; Burger HR; Briner J; Binswanger U
Nephrol Dial Transplant; 1995; 10(2):287-9. PubMed ID: 7753469
[No Abstract] [Full Text] [Related]
17. [Fabry's disease in children. Clinical and biological study of one family. Structure and ultrastructure of the kidney in a hemizygote and a heterozygote].
Desbois JC; Mazière JC; Gubler MC; Allaneau C; Verhaeghe MP; Herrault A
Ann Pediatr (Paris); 1977 Sep; 24(8-9):575-86. PubMed ID: 16211911
[No Abstract] [Full Text] [Related]
18. Rare case of nephrocalcinosis in the distal tubules caused by hereditary renal hypouricaemia 3 months after kidney transplantation.
Okabayashi Y; Yamamoto I; Komatsuzaki Y; Niikura T; Yamakawa T; Katsumata H; Kawabe M; Katsuma A; Nakada Y; Kobayashi A; Koike Y; Miki J; Yamada H; Tanno Y; Ohkido I; Tsuboi N; Ichida K; Yamamoto H; Yokoo T
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():67-71. PubMed ID: 26971588
[TBL] [Abstract][Full Text] [Related]
19. Immunofluorescence analysis of trihexosylceramide accumulated in the hearts of variant hemizygotes and heterozygotes with Fabry disease.
Itoh K; Takenaka T; Nakao S; Setoguchi M; Tanaka H; Suzuki T; Sakuraba H
Am J Cardiol; 1996 Jul; 78(1):116-7. PubMed ID: 8712102
[TBL] [Abstract][Full Text] [Related]
20. Heterozygote to homozygote related living donor liver transplantation in maple syrup urine disease: a case report.
Patel N; Loveland J; Zuckerman M; Moshesh P; Britz R; Botha J
Pediatr Transplant; 2015 May; 19(3):E62-5. PubMed ID: 25677046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
